This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...